Split History
ETFs Holding DVAX »    DVAX Historical Stock Prices »
Video: What is a Stock Split?

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Dynavax Technologies is a biopharmaceutical company focused on utilizing the power of the body's innate and adaptive immune responses through toll-like receptor (TLR) stimulation. Co.'s commercial product, HEPLISAV-B™ (Hepatitis B Vaccine (Recombinant), Adjuvanted), has been approved by the U.S. Food and Drug Administration for prevention of infection caused by all known subtypes of hepatitis B virus in adults age 18 years and older. Co.'s pipeline of product candidates includes: SD-101, a C Class CpG TLR9 agonist for treatment of cancer, including high interferon induction; and a TLR9 agonist, DV281, designed for delivery to lung cancer patients as an inhaled aerosol. According to our DVAX split history records, Dynavax Technologies has had 1 split.
DVAX split history picture
Dynavax Technologies (DVAX) has 1 split in our DVAX split history database. The split for DVAX took place on November 10, 2014. This was a 1 for 10 reverse split, meaning for each 10 shares of DVAX owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 100 share position following the split.

When a company such as Dynavax Technologies conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share. Looking at the DVAX split history from start to finish, an original position size of 1000 shares would have turned into 100 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Dynavax Technologies shares, starting with a $10,000 purchase of DVAX, presented on a split-history-adjusted basis factoring in the complete DVAX split history. DVAX split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 07/20/2009
End date: 07/19/2019
Start price/share: $14.80
End price/share: $3.66
Dividends collected/share: $0.00
Total return: -75.27%
Average Annual Total Return: -13.04%
Starting investment: $10,000.00
Ending investment: $2,471.89
Years: 10.00
Date Ratio
11/10/20141 for 10
DVAX is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

DYNT Split History
ECTE Split History
EIGR Split History
ELGX Split History
ENSG Split History
ENZ Split History
EPRS Split History
ESMC Split History
ESRX Split History
ETRM Split History

Also explore: DVAX shares outstanding history

Neuralstem, Inc. (CUR)
Francesca's Holdings Corporation (FRAN)
China Green Agriculture, Inc. (CGA)
Xenetic Biosciences, Inc. (XBIO)
Yuma Energy, Inc. (YUMA)
Avinger, Inc. (AVGR)
Sonoma Pharmaceuticals, Inc. (SOMA)
Hudson Global, Inc. (HSON)
Jaguar Health, Inc. (JAGX)
Cesca Therapeutics Inc. (KOOL)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

DVAX Insider Buying

DVAX Split History | www.SplitHistory.com | Copyright © 2013 - 2019, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.